Vivara Participações S.A (VIVA3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 16 Oct 2026
Key indicators
| Last close | BRL 26.69 |
|---|---|
| 52-week range | 20.04 – 35.88 |
| Return, 1 month / 3 months | +17.5% / +18.9% |
| Return, 1 year / 3 years | +0.7% / +4.9% |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 40.6% |
| Worst drawdown (1 year) | -42.2% |
| Average daily value traded | 75.60M BRL |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vivara Participações S.A. is a Brazilian jewellery company that designs, makes and sells jewellery, watches and accessories. Its products are offered under its Vivara and Life brands, ranging from gold and diamond pieces to everyday fashion jewellery. The company serves retail customers across Brazil through its own store network and online channels, and it is headquartered in São Paulo.
Vivara Participações S.A trades under the code VIVA3 on the Sao Paulo Exchange in Brazil, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vivara Participações S.A (VIVA3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 26.69 on 16 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 727 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.7% and over the last three months it rose 18.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 43 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 6.2% | ||
| From 52-week high | -24.5% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 18.9% | ||
| 6-month return | -2.9% | ||
| 12-month return, skipping the last month | -14.3% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -42.2% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 75.60M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −7.6% |
|---|---|
| 1 month | +17.5% |
| 3 months | +18.9% |
| 6 months | −2.9% |
| 1 year | +0.7% |
| 3 years | +4.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 23.32 / 25.12 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.13 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Dec 2025 | BRL 0.6977 |
| 22 Apr 2025 | BRL 0.6602 |
| 29 Apr 2024 | BRL 0.3679 |
| 27 Apr 2023 | BRL 0.3633 |
| 29 Apr 2022 | BRL 0.0539 |
| 27 Dec 2021 | BRL 0.2752 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.